InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Sciascia Thomas. Insider active across 1 company, notably Trevi Therapeutics, Inc.. In total, 4 disclosures have been recorded. History available since 29 May 2024. The latest transaction was disclosed on 25 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
SCIASCIA THOMAS is a declarant linked to Trevi Therapeutics, Inc. as Chief Scientific Officer. The record shows 4 filings in total, and the sampled recent filings run from 2024-05-31 to 2025-03-26, with the modal transaction nature listed as option exercise. The buy and sell volumes in this sample are EUR 0 and EUR 0.